We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$86.8M
Cap. Flow %
32.16%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$931K
2
SKM icon
SK Telecom
SKM
+$871K
3
MRNA icon
Moderna
MRNA
+$825K
4
COP icon
ConocoPhillips
COP
+$786K
5
PXD
Pioneer Natural Resource Co.
PXD
+$785K

Top Sells

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$1.83M
2
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
+$1.76M
3
MOS icon
The Mosaic Company
MOS
+$928K
4
STR
Sitio Royalties
STR
+$559K
5
GFI icon
Gold Fields
GFI
+$512K

Sector Composition

Rank Sector Weight
1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VKTX icon
476
Viking Therapeutics
VKTX
$3.93B
– –
-32,708
Closed -$98K
VOR icon
477
Vor Biopharma
VOR
$1.08B
– –
-629
Closed -$76K
VSTM icon
478
Verastem
VSTM
$547M
– –
-5,744
Closed -$97K
YMAB
479
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-23,646
Closed -$281K
LENZ
480
LENZ Therapeutics
LENZ
$184M
– –
-2,138
Closed -$76K
QTTB icon
481
Q32 Bio
QTTB
$467M
– –
-1,972
Closed -$108K
KLRS
482
Kalaris Therapeutics
KLRS
$79.5M
– –
-455
Closed -$71K
CMRX
483
DELISTED
Chimerix, Inc.
CMRX
– –
-25,976
Closed -$119K
GRTS
484
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-13,538
Closed -$56K
GTHX
485
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-15,188
Closed -$115K
VBIV
486
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-2,307
Closed -$115K
MRNS
487
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-15,039
Closed -$141K
KNTE
488
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-9,184
Closed -$103K
GRCL
489
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
– –
-24,728
Closed -$58K
AMTI
490
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
– –
-11,621
Closed -$87K
HGEN
491
DELISTED
HUMANIGEN, INC.
HGEN
– –
-36,572
Closed -$110K
EVLO
492
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
– –
-1,051
Closed -$71K
PRVB
493
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-26,467
Closed -$194K
RUBY
494
DELISTED
Rubius Therapeutics, Inc
RUBY
– –
-12,052
Closed -$66K
CLVS
495
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-57,437
Closed -$116K
FMTX
496
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-11,234
Closed -$104K
TPTX
497
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-3,893
Closed -$105K
BPMP
498
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
– –
-104,162
Closed -$1.76M
SUNS
499
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
– –
-23,152
Closed -$328K
MBT
500
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$0 ﹤0.01%
193,601
– –
17 18 19
20
21

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, Virtus ETF Advisers held 501 positions worth $270M, up 21% from $223M the previous quarter. Its ten largest holdings account for 7.5% of the portfolio.

Virtus ETF Advisers deployed $86.8M of net new capital in Q2 2022, opening 128 new positions and adding to 202 existing holdings. Its largest new stake was ConocoPhillips: 7,627 shares worth $685K.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Agnico Eagle Mines, an estimated $1.83M trimmed.

  • Virtus ETF Advisers's largest Q2 2022 buy was ConocoPhillips: 7,627 shares worth $685K.
  • Virtus ETF Advisers added most to Realty Income in Q2 2022, an estimated $931K increase.
  • Virtus ETF Advisers's biggest Q2 2022 reduction was Agnico Eagle Mines, cutting an estimated $1.83M.
  • Virtus ETF Advisers fully exited BP Midstream Partners LP Common Units representing Limited Partner Interests in Q2 2022, selling an estimated $1.76M.
  • Virtus ETF Advisers's ten largest holdings make up 7.5% of its $270M portfolio in Q2 2022.
  • Virtus ETF Advisers opened 128 new positions and closed 67 in Q2 2022.
  • Virtus ETF Advisers's portfolio value rose 21% quarter-over-quarter to $270M.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.